The hemagglutinin-inhibiting peptide PD-001 was co-developed with Tokyo Metropolitan Medical Research Institute and successfully tested on cynomolgus monkeys.
PeptiDream news release, June 29, 2016
PeptiDream Co. starts pre-clinical studies on anti-influenza drug